Evidence map›Paper›PMID 40910325›Full record

ArticleThe Canadian journal of urology2025

Step-by-step anatomical photovaporization of the prostate using 180-W XPS greenlight laser: optimizing functional outcomes through energy modulation.

Fabrizio Di Maida, Francesca Oriti, Antonio Andrea Grosso, Francesco Sessa, Daniele Paganelli, Vincenzo Salamone, Sara Costagli, Francesca Solazzi, Luca Lambertini, Matteo Salvi and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in The Canadian journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Fabrizio Di MaidaDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.
Francesca OritiDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.
Antonio Andrea GrossoDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.
Francesco SessaDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, Florence, 50134, Italy.
Daniele PaganelliDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.
Vincenzo SalamoneDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.
Sara CostagliDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.
Francesca SolazziDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.
Luca LambertiniDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.
Matteo SalviDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.
Michele Di DioDivision of Urology, Department of Surgery, Annunziata Hospital, Cosenza, 87100, Italy.
Andrea MariDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.
Rino OritiDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.
Andrea MinerviniDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, 50134, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe surgical management of patients with benign prostatic hyperplasia (BPH) has considerably evolved through recent years. Nonetheless, benefits and harms of several laser procedures are still to be determined. The study aimed to report perioperative and early functional results of patients treated with anatomical photo vaporization of the prostate (aPVP).

methodsData from consecutive patients treated with aPVP by using a 180-W XPS GreenLight laser were prospectively collected in a single tertiary center between 2020 and 2023. The surgical procedure was divided into a modular step-by-step fashion. Patients were asked to complete self-administered questionnaires at baseline and during follow-up visits.

resultsOverall, 176 consecutive patients were enrolled. Median age was 65 [interquartile range (IQR) 63-72] years. The baseline median prostate volume was 61.2 (IQR 52.5-71.0) mL, and the median max flow rate (Q

conclusionsaPVP with 180-W XPS GreenLight laser is a safe and effective technique showing worthy early functional results. The limitation of the energy delivered in some key phases of the procedure may be associated with a significant reduction in postoperative irritative symptoms. The shape and dimensions of the prostate also play a critical role in determining the total energy required for complete adenoma removal.

Indexed as

Laser TherapyProstateProstatectomyProstatic HyperplasiaAgedHumansMaleMiddle AgedProspective StudiesTreatment Outcomeanatomicalgreenlaserprostatevaporization

Identifiers

PMID40910325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.